About 13 channels for "MedWatch"

Based in Fresno, California, Community Health System is Central California's largest healthcare provider. We operate a health plan, physician network, medical foundation and four hospitals -- Community Regional Medical Center, Clovis Community Medical Center, Fresno Heart & Surgical Hospital and Community Behavioral Health Center -- several long-term care, outpatient, other health care facilities and a physician residency program in conjunction with the University of California, San Francisco.

Sickle Cell Speaks brings those whose lives are affected by sickle cell together. Our intent is to dispel misconceptions, break down stigmas, and inspire hope by offering educational resources and providing a platform where stories of life with sickle cell are shared. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider. Sponsored by Pfizer Inc. US Only. Video content is intended to be viewed in the context of its original location online. Reporting Adverse events: Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report adverse events related to Pfizer products by calling 1-800-439-1985 (U.S. Only). You may also contact the U.S. Food and Drug Administration (FDA) directly at http://www.fda.gov/MedWatch or call 1-800-FDA-1088. P-UNB-US-01366 v1 See our community guidelines here: https://sicklecellspeaks.com/youtube-guidelines.pdf

Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, is the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis (droopy eyelid) in adults. The content on this channel is not, nor is it intended to be, medical advice, consultations, diagnoses, or treatment recommendations. Consult your eye care professional for more information and to find out if Upneeq® is right for you. If you believe you have had an adverse event or side effect possibly due to a RVL Pharmaceuticals medication, please report these immediately by visiting www.fda.gov/medwatch or by calling 1-800-FDA-1088. We also encourage you to call RVL Pharmaceuticals directly at 877-482-3788. Should comments or questions include any reports of adverse events associated with our medicines, we may need to contact you to find out more information. ©2024 RVL Pharmaceuticals, Inc. Upneeq® is a registered trademark of RVL Pharmaceuticals, Inc.

PHEXXI® (lactic acid, citric acid, and potassium bitartrate) is an on-demand method of birth control used to prevent pregnancy. PHEXXI® is not effective when used after sex. If you have had a history of repeated urinary tract infections or other urinary tract problems, avoid Phexxi®. Click the links below to read full safety and prescribing information. For more information about Phexxi®, talk to your healthcare provider and see full Product and Patient Information at https://phexxi.com. Please report side effects by contacting Evofem Biosciences® toll-free at 1-833-EVFMBIO or contact FDA at 1-800-FDA-1088 or https://fda.gov/medwatch. Phexxi is a registered trademark of Evofem Biosciences, Inc. Trademarks, registered or otherwise, are the property of their respective owner(s). © 2021 Evofem Biosciences, Inc.

iLink®, the only FDA-approved cross-linking procedure for the treatment of progressive keratoconus.  Visit www.glaukos-ilink.com for Important Safety Information and to obtain the FDA-approved product labeling.  You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.  APPROVED USES  Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) are used with the KXL® System in corneal cross-linking to treat eyes in which the cornea, the clear dome-shaped surface that covers the front of the eye, has been weakened from the progression of the disease keratoconus or following refractive surgery, a method for correcting or improving your vision.  Tell your healthcare provider if you are pregnant or plan to become pregnant.

This is the official YouTube channel for ENHERTU® (fam-trastuzumab deruxtecan-nxki). Here you will find videos from Daiichi Sankyo and AstraZeneca to explore and share. This content is intended for US patients/consumers and US healthcare professionals only, as indicated by the specified playlists. The content is for informational purposes only and is not intended to be a substitute for medical advice. To report SUSPECTED ADVERSE REACTIONS, contact Daiichi Sankyo, Inc. at 1-877-437-7763 or FDA at 1-800-FDA-1088 or fda.gov/medwatch. Please see the links below for Important Safety Information and full Prescribing Information, including Boxed WARNINGS, and Medication Guide.

Full Pl: nurtec.com/pi ISI & Approved Uses: nurtec.com/#isi This channel is for US residents only & the video content is intended to be viewed in the context of its original location online. The info provided is for educational purposes only & is not intended to replace discussions with a HCP. Nurtec ODT is for acute treatment of migraine & preventive treatment of episodic migraine in adults. Select Safety Info: Don't take if allergic to Nurtec ODT. Allergic reactions include trouble breathing, rash & swelling of the face, mouth, tongue, or throat. Most common side effects were nausea & indigestion/stomach pain. Patients should always ask their doctors for medical advice about adverse events. You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the US FDA directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088. © 2023 Pfizer Inc. All rights reserved. June 2023. PP-NNT-USA-2592.

Welcome to the official VTAMA® (tapinarof) cream, 1% YouTube page. VTAMA cream is a prescription steroid-free cream used on the skin (topical) to treat mild, moderate, or severe plaque psoriasis in adults. To see results from VTAMA cream, visit https://www.vtama.com/about/what-is-vtama#patient-images IMPORTANT SAFETY INFORMATION: INDICATION: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults. ADVERSE EVENTS: The most common adverse reactions (incidence ≥ 1%) in subjects treated with VTAMA cream were folliculitis (red raised bumps around the hair pores), nasopharyngitis (pain or swelling in the nose and throat), contact dermatitis (skin rash or irritation, including itching and redness, peeling, burning, or stinging), headache, pruritus (itching), and influenza (flu). You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

MedWatch Today is a weekly, half-hour, health news TV show produced by KSEE24 and CBS47 featuring stories exclusively from Community Medical Centers – a locally owned, not-for-profit public benefit organization based in Fresno, CA.

To learn more about TRELEGY ELLIPTA (fluticasone furoate, umeclidinium & vilanterol), go to www.TRELEGY.com. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. For US audiences only. The shape of the ELLIPTA inhaler is a trademark of the GSK group of companies. Trademarks are property of their respective owners. ©2023 GSK or licensor. FVUOGM230021 May 2023 Produced in USA.

Welcome to the official YouTube® channel for XHANCE® nasal spray. Find out more information about XHANCE® and view videos. To report SUSPECTED ADVERSE REACTIONS, contact OptiNose US, Inc. at 1-833-678-6673 and safety@optinose.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. See the links below or visit XHANCE.com for Important Safety Information, full Prescribing Information, Patient Information, and Instructions for Use. XHANCE® and OPTINOSE® are registered trademarks of OptiNose, Inc. ©2021, OptiNose US, Inc. All rights reserved. XHA-21-10135 08/2021

Welcome to the EPIPEN® (epinephrine injection, USP) Auto-Injector Official YouTube Channel. Explore this channel or visit https://www.epipen.com to learn more about EPIPEN or EPIPEN JR Auto-Injectors. You are encouraged to report negative side effects of prescription drugs to the FDA. Call 1-800-FDA-1088 or visit: www.fda.gov/medwatch See the links below or visit www.epipen.com for full Prescribing and Patient Information, including Instructions for Use. EPIPEN, EPIPEN JR, EPIPEN 2-PAK and EPIPEN JR 2-PAK are registered trademarks of Mylan Inc. a Viatris Company. All other trademarks are the property of their respective owner. © 2023 Viatris Inc. All rights reserved. 4/23 EPI-2022-0096 V3

The makers of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% and the Pacer National Bullying Prevention Center are proud to introduce the Band Together to Banish Bullying Project. We're partnering with three of today's top musical artists to try and turn the negativity of bullying into something positive: a brand-new song they're going to write. Let your voice inspire ours, and let's band together to banish bullying. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.